Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  INC Research Holdings Inc    

INC RESEARCH HOLDINGS INC
Mes dernières consult.
Most popular
  Report  
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Pomerantz Law Firm Investigates Claims On Behalf of Investors of INC Research Holdings, Inc. - INCR

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/10/2017 | 05:37pm CEST

NEW YORK, Nov. 10, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of INC Research Holdings, Inc. ("INC Research" or the "Company") (NASDAQ: INCR). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980.

The investigation concerns whether INC Research and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here to join a class action]

On August 1, 2017, INC Research and inVentiv Health, Inc. ("inVentiv Health") announced the completion of a merger between the two companies. On November 9, 2017, INC Research reported its first financial results after combining with inVentiv Health. The Company's combined results were negatively impacted by merger-related expenses, an impairment charge and increased amortization expenses.

On this news, INC Research's share price fell $16.35, or 28.43%, to close at $41.15 on November 9, 2017.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

CONTACT:
Robert S. Willoughby
Pomerantz LLP
[email protected]

View original content:http://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-inc-research-holdings-inc--incr-300553910.html

SOURCE Pomerantz LLP


© PRNewswire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on INC RESEARCH HOLDINGS INC
06/22Syneos Health to Share Strategies Designed to Meet the Needs of Patients, Pay..
GL
06/22SYNEOS HEALTH : and Elligo Announce Strategic Collaboration to Advance Clinical ..
AQ
06/21Syneos Health and Elligo Announce Strategic Collaboration to Advance Clinical..
GL
06/13SYNEOS HEALTH : to lay off 98 amid changing business needs
AQ
06/08SYNEOS HEALTH : Consulting Releases 10th Annual Biopharmaceutical Dealmakers Sur..
AQ
06/06SYNEOS HEALTH : Consulting Releases 10th Annual Biopharmaceutical Dealmakers Sur..
AQ
06/06SYNEOS HEALTH : to Present Actionable Commercial Insights Designed for Biopharma..
AQ
06/05SYNEOS HEALTH : Consulting Releases 10th Annual Biopharmaceutical Dealmakers Sur..
AQ
06/05Syneos Health to Present Actionable Commercial Insights Designed for Biopharm..
GL
05/25SYNEOS HEALTH, INC. : Change in Directors or Principal Officers, Submission of M..
AQ
More news
News from SeekingAlpha
01/03INC Research CFO exiting post at April's end 
2017INC Research Holdings 2017 Q3 - Results - Earnings Call Slides 
2017INC Research's (INCR) CEO Alistair MacDonald on Q3 2017 Results - Earnings Ca.. 
2017Midday Gainers / Losers 
2017INC Research misses by $0.08, misses on revenue